Anti-HIV/ARVs: registrations due for renewal
5 active registrations among the HIV (antiretroviral) medicines Ogbogwu tracks carry expiry dates between August 2026 and August 2027, in our August 2026 Greenbook copy. An expiry means a renewal is due — holders routinely renew, and listings can lag the paperwork. Nothing here says a product is leaving the market.
August 2026 (2)
- Abacavir & Lamivudine Tablets 600/300 mgexpires 2026-08-25
- Lamivudine & Tenofovir Disoproxil Fumarate Tablets 300/300 mgexpires 2026-08-25
September 2026 (2)
- Dolutegravir (as Sodium)/ Lamivudine/Tenofovir Disoproxil Fumarate 50 mg/300 mg/300 mg Tabletsexpires 2026-09-27
- Viropil Tabletsexpires 2026-09-27
December 2026 (1)
- Tenofovir Disoproxil Fumerate/Lamivudine/Dolutegravirexpires 2026-12-16
Wholesaling one of these lines? Ask your supplier about the renewal, and check the number on any pack before a large order. The market view of this category is in the HIV (antiretroviral) supply report.
Is one of these your registration?
Your renewal window is open. And if you're a manufacturer or importer working through Nigerian registration, start here.
Supplying the Nigerian marketOther categories on watch
- Antibiotics (262)
- Pain & Fever (118)
- Hypertension (66)
- Antimalarials (53)
- Digestive Health (50)
- Vitamins & Supplements (34)
- Allergy (33)
- Respiratory (33)
- Dermatology (29)
- Diabetes (26)
- Eye & Ear Drops (24)
- Sexual Health (15)
- Cholesterol (14)
- Antifungals (12)
- Antiparasitics (9)
- Cough, Cold & Flu (8)
- Blood Thinners (6)
- Reproductive Health (6)
Every date is quoted from that registration's own public Greenbook record as of our dated copy; the register can change after our copy is taken, and renewal paperwork often lands before a listing updates. This page is a record of dates, not a prediction that any product will leave the market.